At the news
? NEUTRALIMPACT 5/10 8-K filed Nov 2, 2026 at 08:07 ET
Veeco and Axcelis announced a delay in the expected closing of their all-stock merger, now anticipated by the end of Q1 2027 (previously expected sooner). The delay is due to pending regulatory approval from China's SAMR and the need to re-file under the HSR Act as the current clearance expires. The merger terms remain unchanged at 0.3575 Axcelis shares per Veeco share.
- Merger closing timeline pushed to end of Q1 2027 from a prior undisclosed date.
- Pending SAMR (China) regulatory approval is the primary gating item.
- HSR Act clearance is expiring; parties will make a new submission.
- Exchange ratio remains 0.3575 Axcelis shares per Veeco share.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access